We are pleased to introduce DAXXIFY™
The only long-lasting, peptide-powered frown line treatment
We’re one of the first exclusive providers to offer this innovative treatment.
Call our office today to book your appointment, and visit DAXXIFY.com to learn more.
Featured Service: DAXXIFY®
For Men & Women
DAXXIFY® is a prescription medicine injected into muscles and used in adults to temporarily improve the look of moderate to severe frown lines between the eyebrows.
DAXXIFY® helps smooth moderate to severe lines between the brows. It is the only long-lasting frown line treatment powered by a peptide, with results that last, on average, six months and up to 9 months for some.
With DAXXIFY®, you can keep your frown lines smoother for a year with as few as two treatments.*
Conventional injectables last 3 – 4 months and require up to 4 treatments yearly to maintain results. Nearly 90% of patients say they wish the effects lasted longer.
TWICE A YEAR
Results last on average 6 months and up to 9 months for some.
Results May Vary
DAXXIFY® may last up to twice as long as conventional frown line treatments for some.*
*Conventional frown line treatments last 3-4 months. At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment with DAXXIFY®. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months later.
Why Are Peptides Important?
All frown line treatments require a unique ingredient to stabilize botulinum toxin A,the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA) as a blood product stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant. DAXXIFY® is unique because it is the only formulation with a novel peptide as a stabilizer and does not contain human or animal byproducts.
Is DAXXIFY® well studied?
DAXXIFY® was studied in the largest-ever clinical study conducted for a frown line treatment and included more than 2,400 people of different ages and skin types.
- There were no serious treatment-related side effects in clinical trials for
DAXXIFY® - The active ingredient in DAXXIFY® is botulinum toxin type A, used in frown line treatments for more than 20 years
- 96% of people treated with DAXXIFY® were satisfied with their results†
†96% of patients reported they were satisfied on a 7-point scale when evaluated at four weeks in clinical studies.
